Cargando…

Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations

Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease. Circulating tumor cells (CTC) in the blood are hypothesized as the means of systemic tumor spread. Blood obtained from healthy donors and patients with PDAC was therefore subject to size-based CTC-isolation. We additionally compared K...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kulemann, Birte, Rösch, Stephanie, Seifert, Sindy, Timme, Sylvia, Bronsert, Peter, Seifert, Gabriel, Martini, Verena, Kuvendjiska, Jasmina, Glatz, Torben, Hussung, Saskia, Fritsch, Ralph, Becker, Heiko, Pitman, Martha B., Hoeppner, Jens
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5495768/ https://www.ncbi.nlm.nih.gov/pubmed/28674438 http://dx.doi.org/10.1038/s41598-017-04601-z

Ejemplares similares

Author Correction: Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations
por: Kulemann, Birte, et al.
Publicado: (2017)

Non-Metastatic Esophageal Adenocarcinoma: Circulating Tumor Cells in the Course of Multimodal Tumor Treatment
por: Kuvendjiska, Jasmina, et al.
Publicado: (2019)

Pattern of Recurrence and Patient Survival after Perioperative Chemotherapy with 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) for Locally Advanced Esophagogastric Adenocarcinoma in Patients Treated Outside Clinical Trials
por: Glatz, Torben, et al.
Publicado: (2020)

Circulating Tumor Cells in Pancreatic Cancer: Current Perspectives
por: Martini, Verena, et al.
Publicado: (2019)

Hybrid Minimally Invasive Esophagectomy–Surgical Technique and Results
por: Kuvendjiska, Jasmina, et al.
Publicado: (2019)

Cancer-associated Macrophage-like Cells in Patients with Non-metastatic Adenocarcinoma of the Esophagus - Cytomorphological Heterogeneity
por: Braun, Clara, et al.
Publicado: (2023)

Circulating Epithelial Cells in Patients with Intraductal Papillary Mucinous Neoplasm of the Pancreas
por: Kuvendjiska, Jasmina, et al.
Publicado: (2023)

Pathological complete response in multimodal treatment of esophageal cancer: a retrospective cohort study
por: Hipp, Julian, et al.
Publicado: (2022)

The degree of local inflammatory response after colonic resection depends on the surgical approach: an observational study in 61 patients
por: Glatz, Torben, et al.
Publicado: (2015)

The effect of pasireotide on intestinal anastomotic healing with and without whole-body irradiation in a rat model
por: Seifert, Gabriel J., et al.
Publicado: (2018)

Oncological recurrence following pathological complete response after neoadjuvant treatment in patients with esophageal cancer — a retrospective cohort study
por: Hipp, Julian, et al.
Publicado: (2023)

Postoperative fluid overload is a risk factor for adverse surgical outcome in patients undergoing esophagectomy for esophageal cancer: a retrospective study in 335 patients
por: Glatz, Torben, et al.
Publicado: (2017)

Complications after pancreaticoduodenectomy are associated with higher amounts of intra- and postoperative fluid therapy: A single center retrospective cohort study
por: Kulemann, Birte, et al.
Publicado: (2017)

The Prognostic Impact of the Carcinoembryonic Antigen in Ampullary Cancer - A Retrospective Single Center Study
por: Fuellgraf, Hannah, et al.
Publicado: (2017)

Metastasis and Tumor Cell Migration of Solid Tumors
por: Hoeppner, Jens, et al.
Publicado: (2021)

Mesopancreatic Stromal Clearance Defines Curative Resection of Pancreatic Head Cancer and Can Be Predicted Preoperatively by Radiologic Parameters: A Retrospective Study
por: Wellner, Ulrich F., et al.
Publicado: (2016)

Prognostic impact of tumor budding and EMT in periampullary adenocarcinoma: a quantitative approach
por: Kocsmár, Éva, et al.
Publicado: (2020)

ADAM9 contributes to vascular invasion in pancreatic ductal adenocarcinoma
por: Oria, Victor O., et al.
Publicado: (2019)

Longitudinal analysis of cell-free mutated KRAS and CA 19–9 predicts survival following curative resection of pancreatic cancer
por: Hussung, Saskia, et al.
Publicado: (2021)

Proximal gastrectomy and double-tract reconstruction vs total gastrectomy in gastric and gastro-esophageal junction cancer patients — a systematic review and meta-analysis protocol (PROSPERO registration number: CRD42021291500)
por: Hipp, Julian, et al.
Publicado: (2023)

Postoperative Hiatal Hernia after Ivor Lewis Esophagectomy—A Growing Problem in the Age of Minimally Invasive Surgery
por: Kuvendjiska, Jasmina, et al.
Publicado: (2023)

Identification and Validation of a Diagnostic and Prognostic Multi-Gene Biomarker Panel for Pancreatic Ductal Adenocarcinoma
por: Klett, Hagen, et al.
Publicado: (2018)

Plasma biomarkers for prediction of early tumor recurrence after resection of pancreatic ductal adenocarcinoma
por: Rittmann, Marie-Claire, et al.
Publicado: (2021)

ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286)
por: Hoeppner, Jens, et al.
Publicado: (2016)

Conditional Gene Targeting Reveals Cell Type-Specific Roles of the Lysosomal Protease Cathepsin L in Mammary Tumor Progression
por: Parigiani, María Alejandra, et al.
Publicado: (2020)

Pregnancy Specific β-1 Glycoprotein 1 is Expressed in Pancreatic Ductal Adenocarcinoma and its Subcellular Localization Correlates with Overall Survival
por: Shahinian, Jasmin H., et al.
Publicado: (2016)

Targeting the Tumor Microenvironment: An Unexplored Strategy for Mutant KRAS Tumors
por: Dias Carvalho, Patrícia, et al.
Publicado: (2019)

Perioperative FLOT chemotherapy plus surgery for oligometastatic esophagogastric adenocarcinoma: surgical outcome and overall survival
por: Runkel, Mira, et al.
Publicado: (2021)

Personalized Treatment Selection and Disease Monitoring Using Circulating Tumor DNA Profiling in Real-World Cancer Patient Management
por: Wehrle, Julius, et al.
Publicado: (2020)

Targeting KRAS in Solid Tumors: Current Challenges and Future Opportunities of Novel KRAS Inhibitors
por: Indini, Alice, et al.
Publicado: (2021)

KRAS mutant colorectal tumors: Past and present
por: Brand, Toni M., et al.
Publicado: (2012)

Twists and turns in Kras-driven tumor initiation
por: Maru, Yoshiaki, et al.
Publicado: (2021)

Transformation of immunosuppressive mtKRAS tumors into immunostimulatory tumors by Nerofe and Doxorubicin
por: Ohana, Joel, et al.
Publicado: (2023)

Metabolic Profiling of Early and Late Recurrent Pancreatic Ductal Adenocarcinoma Using Patient-Derived Organoid Cultures
por: Braun, Lukas M., et al.
Publicado: (2020)

Prognostic Implications of PET-Derived Tumor Volume and Uptake in Patients with Neuroendocrine Tumors
por: Weber, Manuel, et al.
Publicado: (2023)

Epidural analgesia and avoidance of blood transfusion are associated with reduced mortality in patients with postoperative pulmonary complications following thoracotomic esophagectomy: a retrospective cohort study of 335 patients
por: Kaufmann, Kai B., et al.
Publicado: (2019)

Comparison of Mutated KRAS and Methylated HOXA9 Tumor-Specific DNA in Advanced Lung Adenocarcinoma
por: Wen, Sara W. C., et al.
Publicado: (2020)

Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab
por: Dunn, Emily F., et al.
Publicado: (2010)

Oncogenic KRAS promotes malignant brain tumors in zebrafish
por: Ju, Bensheng, et al.
Publicado: (2015)

Zebrafish model of KRAS-initiated pancreatic endocrine tumor
por: Oh, Sekyung, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4mgqujn63jmsqv7mo9ddquvqef